Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis

Thromb Haemost. 2008 Feb;99(2):443-4. doi: 10.1160/TH07-11-0670.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antithrombin III / genetics*
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Inflammatory Bowel Diseases / complications*
  • Intracranial Thrombosis / etiology*
  • Intracranial Thrombosis / genetics
  • Male
  • Mutation*
  • Pedigree
  • Risk Factors
  • Thrombophilia / complications*
  • Thrombophilia / genetics
  • Venous Thrombosis / genetics*

Substances

  • antithrombin Cambridge II
  • Antithrombin III